Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of REL-1017 (d-Methadone)
Clinical trial NCT03637361 · COMPLETED
Trial details
- NCT number
- NCT03637361
- Sponsor
- Relmada Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-04
- Primary completion
- 2015-06-02
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.